The suppressive effect of TGF-β on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): A mechanism involved in inhibition of both IL-12 receptor β1 and β2

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 53-63

  Xu, Hui ^a   Zhang, Guang Xian ^a   Wysocka, Maria ^b   Wu, Chang You ^c   Trinchieri, Giorgio ^b   Rostami, Abdolmohamad ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokine receptors; Cytokines; Encephalomyelitis, Allergic; T Lymphocytes

Indexed keywords

AUTOANTIGEN; CYTOKINE RECEPTOR; INTERLEUKIN 12 RECEPTOR; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; SPLEEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034255735     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00278-2     Document Type: Article

References (43)

1. Altare, F., Durandy, A., Lammas, D., Emile, J.F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Doffinger, R., Bernaudin, F., Jeppsson, O., Gollob, J.A., Meinl, E., Segal, A.W., Fischer, A., Kumararatne, D., Casanova, J.L., 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432-1435.
2. Bacon, C.M., Petricoin, 3rd. E.F., Ortaldo, J.R., Rees, R.C., Larner, A.C., Johnston, J.A., O'Shea, J.J., 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 1992, 7307-7311.
3. Becker, K.J., McCarron, R.M., Ruetzler, C., Laban, O., Sternberg, E., Flanders, K.C., Hallenbeck, J.M., 1997. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 94, 10873-10878.
4. Braun, M.C., He, J., Wu, C.Y., Kelsall, B.L., 1999. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med. 189, 541-552.
5. Bright, J.J., Sriram, S., 1998. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161, 1772-1777.
6. Bright, J.J., Du, C., Sriram, S., 1999. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J. Immunol. 162, 6255-6262.
7. Chan, S.H., Perussia, B., Gupta, J.W., Kobayashi, M., Pospisil, M., Young, H.A., Wolf, S.F., Young, D., Clark, S.C., Trinchieri, G., 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173, 869-879.
8. Chang, J.T., Shevach, E.M., Segal, B.M., 1999. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 189, 969-978.
9. Chua, A.O., Wilkinson, V.L., Presky, D.H., Gubler, U., 1995. Cloning and characterization of a mouse IL-12 receptor-beta component. J. Immunol. 155, 4286-4294.
10. de Jong, R., Altare, F., Haagen, I.A., Elferink, D.G., Boer, T., van Breda Vriesman, P.J., Kabel, P.J., Draaisma, J.M., van Dissel, J.T., Kroon, P.P., Casanova, J.L., Ottenhoff, T.H., 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-1438.
11. Fukaura, H., Kent, S.C., Pietrusewicz, M.J., Khoury, S.J., Weiner, H.L., Hafler, D.A., 1996. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70-77.
12. Fulton, S.A., Cross, J.V., Toossi, Z.T., Boom, W.H., 1998. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178, 1105-1114.
13. Galbiati, F., Rogge, L., Guery, J.C., Smiroldo, S., Adorini, L., 1998. Regulation of the IL-12 receptor beta2 subunit by soluble antigen and IL-12 in vivo. Eur. J. Immunol. 28, 209-220.
14. Gately, M.K., Renzetti, L.M., Magram, J., Stern, A.S., Adorini, L., Gubler, U., Presky, D.H., 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521.
15. Gorham, J.D., Guler, M.L., Fenoglio, D., Gubler, U., Murphy, K.M., 1998. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J. Immunol. 161, 1664-1670.
16. Gubler, U., Presky, D.H., 1996. Molecular biology of interleukin-12 receptors. Ann. NY Acad. Sci. 795, 36-40.
17. Hirsch, C.S., Hussain, R., Toossi, Z., Dawood, G., Shahid, F., Ellner, J.J., 1996. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc. Natl. Acad. Sci. USA 93, 3193-3198.
18. Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O'Garra, A., Murphy, K.M., 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
19. Hunter, C.A., Bermudez, L., Beernink, H., Waegell, W., Remington, J.S., 1995. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25, 994-1000.
20. Inobe, J., Slavin, A.J., Komagata, Y., Chen, Y., Liu, L., Weiner, H.L., 1998. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28, 2780-2790.
21. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B., Trinchieri, G., 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
22. Lafaille, J.J., Nagashima, K., Katsuki, M., Tonegawa, S., 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78, 399-408.
23. Maier, C.C., Bhandoola, A., Borden, W., Yui, K., Hayakawa, K., Greene, M.I., 1998. Unique molecular surface features of in vivo tolerized T cells. Proc. Natl. Acad. Sci. USA 95, 4499-4503.
24. Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M.P., Maggi, E., Trinchieri, G., Romagnani, S., 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
25. McCartney-Francis, N.L., Frazier-Jessen, M., Wahl, S.M., 1998. TGF-beta: a balancing act. Int. Rev. Immunol. 16, 553-580.
26. Neurath, M.F., Fuss, I., Kelsall, B.L., Presky, D.H., Waegell, W., Strober, W., 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J. Exp. Med. 183, 2605-2616.
27. O'Shea, J.J., 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7, 1-11, [published erratum appears in Immunity 1997 (Sept);7(3):following 444].
28. Pardoux, C., Ma, X., Gobert, S., Pellegrini, S., Mayeux, P., Gay, F., Trinchieri, G., Chouaib, S., 1999. Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling. Blood 93, 1448-1455.
29. Piccirillo, C.A., Chang, Y., Prud'homme, G.J., 1998. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J. Immunol. 161, 3950-3956.
30. Presky, D.H., Yang, H., Minetti, L.J., Chua, A.O., Nabavi, N., Wu, C.Y., Gately, M.K., Gubler, U., 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93, 14002-14007.
31. Presky, D.H., Minetti, L.J., Gillessen, S., Wilkinson, V.L., Wu, C.Y., Gubler, U., Chizzonite, R., Gately, M.K., 1998. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J. Immunol. 160, 2174-2179.
32. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D.H., Gubler, U., Sinigaglia, F., 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825-831.
33. Rogge, L., Papi, A., Presky, D.H., Biffi, M., Minetti, L.J., Miotto, D., Agostini, C., Semenzato, G., Fabbri, L.M., Sinigaglia, F., 1999. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J. Immunol. 162, 3926-3932.
34. Seder, R.A., Gazzinelli, R., Sher, A., Paul, W.E., 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
35. Seo, N., Tokura, Y., Takigawa, M., Egawa, K., 1999. Depletion of IL-10-and TGF-beta-producing regulatory gammadelta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J. Immunol. 163, 242-249.
36. Sudarshan, C., Galon, J., Zhou, Y., O'Shea, J.J., 1999. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs. J. Immunol. 162, 2974-2981.
37. Szabo, S.J., Dighe, A.S., Gubler, U., Murphy, K.M., 1997. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824.
38. Trinchieri, G., 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243.
39. Trinchieri, G., Scott, P., 1999. Interleukin-12: basic principles and clinical applications. Curr. Top. Microbiol. Immunol. 238, 57-78.
40. Wu, C., Warner, R.R., Wang, X., Presky, D.H., Gately, M.K., 1997. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur. J. Immunol. 27, 147-154.
41. Wu, C.Y., Wang, K., McDyer, J.F., Seder, R.A., 1998. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161, 2723-2730.
42. Xu, H., Rizzo, L.V., Silver, P.B., Caspi, R.R., 1997. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol. 178, 69-78.
43. Zhang, M., Gong, J., Presky, D.H., Xue, W., Barnes, P.F., 1999. Expression of the IL-12 receptor beta1 and beta2 subunits in human tuberculosis. J. Immunol. 162, 2441-2447.